🇺🇸 Psyllium husks in United States
305 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 305
Most-reported reactions
- Constipation — 46 reports (15.08%)
- Pain — 39 reports (12.79%)
- Off Label Use — 34 reports (11.15%)
- Fall — 28 reports (9.18%)
- Drug Ineffective — 27 reports (8.85%)
- Fatigue — 27 reports (8.85%)
- Headache — 27 reports (8.85%)
- Hypertension — 26 reports (8.52%)
- Orthostatic Hypotension — 26 reports (8.52%)
- Hypotension — 25 reports (8.2%)
Other Gastroenterology approved in United States
Frequently asked questions
Is Psyllium husks approved in United States?
Psyllium husks does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Psyllium husks in United States?
Aalborg University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.